{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:01:44Z","timestamp":1790820104836,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jtha.2025.07.010","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T23:09:49Z","timestamp":1753225789000},"page":"3134-3147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictors of immune tolerance induction success in 231 children with severe hemophilia A with high-titer inhibitors \u2013 lessons learned from the PedNet prospective cohort study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5350-1763","authenticated-orcid":false,"given":"Manuel","family":"Carcao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-2439","authenticated-orcid":false,"given":"Christoph","family":"K\u00f6nigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6058-8350","authenticated-orcid":false,"given":"Nadine G.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3521-1863","authenticated-orcid":false,"given":"Marloes","family":"de Kovel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsbeth","family":"de Boer-Verdonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-2686","authenticated-orcid":false,"given":"Jayashree","family":"Motwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6261-9157","authenticated-orcid":false,"given":"Jan","family":"Blatny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-6244","authenticated-orcid":false,"given":"Martin","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2553-2324","authenticated-orcid":false,"given":"Marijke","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-6613","authenticated-orcid":false,"given":"Kathelijn","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.07.010_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23957","article-title":"Impact of inhibitors on hemophilia a mortality in the United States","volume":"90","author":"Walsh","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.07.010_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/hae.13762","article-title":"The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab","volume":"25","author":"Carcao","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.07.010_bib3","series-title":"WFH Guidelines for the management of hemophilia, 3rd edition","first-page":"1","article-title":"WFH Guidelines for the Management of Hemophilia panelists and co-authors","author":"Srivastava","year":"2020"},{"key":"10.1016\/j.jtha.2025.07.010_bib4","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2014-05-577643","article-title":"Toward optimal therapy for inhibitors in hemophilia","volume":"124","author":"Kempton","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.010_bib5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.thromres.2014.09.010","article-title":"Immune tolerance induction using a factor VIII\/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective study","volume":"134","author":"Robertson","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.07.010_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1182\/blood-2011-08-369132","article-title":"The principal results of the International Immune Tolerance Study: a randomized dose comparison","volume":"119","author":"Hay","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.010_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/bloodadvances.2023011442","article-title":"Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU","volume":"8","author":"Fischer","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.07.010_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/hae.13819","article-title":"Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis","volume":"25","author":"Batsuli","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.07.010_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100020","article-title":"International Genetic and clinical determinants of the Outcome of Immune Tolerance Induction (GO-ITI) study group. Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis","volume":"7","author":"Oomen","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.07.010_bib10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/hae.14847","article-title":"Dilemmas on emicizumab in children with haemophilia A: a survey of strategies from PedNet centres","volume":"29","author":"Ranta","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.07.010_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/hae.14982","article-title":"Haemophilia in the era of novel therapies: where do inhibitors feature in the new landscape?","volume":"30","author":"Meeks","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.07.010_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2516.2010.02225.x","article-title":"Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units","volume":"16","author":"Ter Avest","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.07.010_bib13","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1182\/blood.V86.3.983.983","article-title":"Low-dose immune tolerance induction in hemophilia A patients with inhibitors","volume":"86","author":"Mauser-Bunschoten","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.07.010_bib14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1182\/bloodadvances.2023011974","article-title":"Defining the impact of immune tolerance induction on clinically relevant outcomes in a US cohort of severe hemophilia A","volume":"8","author":"Kempton","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.07.010_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2023.04.002","article-title":"Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors","volume":"226","author":"Sun","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.07.010_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/hae.12608","article-title":"Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two US centres","volume":"21","author":"Nakar","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.07.010_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109115","article-title":"Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors","volume":"242","author":"Zuccherato","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.07.010_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/hae.14431","article-title":"Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors","volume":"28","author":"Di Minno","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2025.07.010_bib19","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3324\/haematol.2023.284095","article-title":"Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A: data from the PedNet Hemophilia Cohort of 1,202 children","volume":"109","author":"Andersson","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.07.010_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.thromres.2020.12.004","article-title":"Incidence of inhibitor development in PUPs with severe Haemophilia A in the CEE region between 2005 and 2015","volume":"198","author":"Blatn\u00fd","year":"2021","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625004337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:23:35Z","timestamp":1790817815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625004337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1538783625004337"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.010","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of immune tolerance induction success in 231 children with severe hemophilia A with high-titer inhibitors \u2013 lessons learned from the PedNet prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}